CASI Pharmaceuticals
CASI
#10982
Rank
A$6.03 M
Marketcap
A$0.29
Share price
0.00%
Change (1 day)
-88.94%
Change (1 year)

EPS for CASI Pharmaceuticals (CASI)

EPS in 2025 (TTM): A-$4.22

According to CASI Pharmaceuticals's latest financial reports the company's current EPS (TTM) is A-$3.92. In 2024 the company made an earnings per share (EPS) of A-$3.62 a decrease over its 2023 EPS that were of A-$2.86.

EPS history for CASI Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$4.2216.6%
2024A-$3.6226.73%
2023A-$2.86-32.89%
2022A-$4.2611.9%
2021A-$3.80-38.44%
2020A-$6.18-8.96%
2019A-$6.7950%
2018A-$4.5377.78%
2017A-$2.555.88%
2016A-$2.40-22.73%
2015A-$3.11-76.09%
2014A-$13.01318.18%
2013A-$3.11-71.79%
2012A-$11.0365.96%
2011A-$6.65-50%
2010A-$13.29-18.97%
2009A-$16.41-63.64%
2008A-$45.123.57%
2007A-$43.56-60.56%
2006A-$110.4697.22%
2005A-$56.01-2.7%
2004A-$57.56-45.59%
2003A-$105.79-61.8%
2002A-$276.92-25.52%
2001A-$371.82-21.38%
2000A-$472.9413.86%
1999A-$415.38149.53%
1998A-$166.4698.15%
1997A-$84.0110.2%
1996A-$76.23